Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2022-09-14 00:00:00 ET · period of report 2022-09-14 · accession 0001864317-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-14 | 2022-09-14 | ALZN | Katzoff David J | CFO | P - Purchase | $1.11 | +10.0K | 28.0K | +56% | +$11.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-14 | P | A | 10,000 | $1.11 | 28,000 | D | — | — |